Figure 1From: Obtaining informed consent for clinical tumor and germline exome sequencing of newly diagnosed childhood cancer patientsBASIC3 clinical study design. CLIA, Clinical Laboratory Improvement Amendments; EHR, electronic health record; GCs, genetic counselors; MDs, pediatric oncologists; WES, whole exome sequencing.Back to article page